FAK in E.coli Pathogenesis
大肠杆菌发病机制中的 FAK
基本信息
- 批准号:6926935
- 负责人:
- 金额:$ 24.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-02-15 至 2007-01-31
- 项目状态:已结题
- 来源:
- 关键词:Escherichia coliactinsactive sitesbacteria infection mechanismcadherinscell adhesioncytoskeletondigital imagingelectron microscopyenzyme activityenzyme mechanismextracellular matrixfibronectinsfocal adhesion kinasegene expressionguanine nucleotide binding proteinhost organism interactionimmunofluorescence techniqueintercellular connectionmolecular assembly /self assemblyprotein structure functionsingle cell analysistransfection /expression vectorvascular endotheliumvascular endothelium permeability
项目摘要
DESCRIPTION (provided by applicant): Bacterial infections present pressing public health challenges. These range from the treatment and prevention of critical illness to the preparation of preventive strategies against bioterrorism. E. coli K1 invades the vascular endothelium of the human brain and causes devastating central nervous system morbidity and mortality. The focal adhesion kinase (pp125FAK) has been implicated as a facilitator of this process. This proposal focuses on the role of FAK in E. coli K1 invasion and disruption of vascular endothelium. The first Specific Aim will examine bacterial invasion. FAK may abet bacterial invasion by either enhancing fibronectin fibrillogenesis and providing points of attachment for invading prokaryotes, or by regulating the dynamic plasticity of subcortical actin networks used by bacteria to enter the cell. These studies will examine the direct relationships between levels of FAK expression, fibronectin and actin microarchitecture, and the success of E. coli K1 invasion. Adenoviral vectors containing dominant negative, wild type, and hyperactive FAK have been prepared to alter FAK activity. The second Specific Aim will examine mechanisms of E. coli-induced changes in vascular endothelial function. The responses and regulation of FAK kinase activity and RhoA activity will be defined during bacterial infection. Endothelial cells with varying levels of FAK activity will be infected with E. coli K1. Changes in the organization of VE-cadherin and beta-catenin in adherens junctions will be measured. Endothelial monolayer permeability will be quantified using an electrical cell-substrate impedance sensing (ECIS). Cytoskeletal force transmission to extracellular matrix will be studied using micropatterned silicon posts to report both local (proximate to discrete invasion events) and global changes in infected cells and monolayers. These studies will provide a more detailed conceptual framework for the identification of therapeutic targets to attenuate E. coli K1 disease in the brain microvasculature. Insights into mechanisms of E .coli invasion that are gained here may provide useful paradigms for approaching E. coli disease in other organ systems.
描述(由申请人提供):细菌感染是迫在眉睫的公共卫生挑战。这些工作范围从治疗和预防危重疾病到制定针对生物恐怖主义的预防战略。大肠杆菌K1侵入人脑的血管内皮,导致毁灭性的中枢神经系统发病率和死亡率。焦点粘附激酶(pp125FAK)被认为是这一过程的促进者。本研究的重点是FAK在大肠杆菌K1侵袭和破坏血管内皮中的作用。第一个特异性目标是检查细菌入侵。FAK可能通过增强纤维连接蛋白纤维形成并为入侵的原核生物提供附着点,或通过调节细菌进入细胞所使用的皮质下肌动蛋白网络的动态可塑性来促进细菌的入侵。这些研究将检验FAK表达水平、纤维连接蛋白和肌动蛋白微结构与大肠杆菌K1侵袭成功之间的直接关系。腺病毒载体含有显性阴性、野生型和过度活跃的FAK,可以改变FAK的活性。第二个特定目标将研究大肠杆菌诱导血管内皮功能改变的机制。FAK激酶活性和RhoA活性的响应和调控将在细菌感染期间确定。具有不同水平FAK活性的内皮细胞将被大肠杆菌K1感染。将测量粘附连接中VE-cadherin和β -catenin组织的变化。内皮单层渗透性将使用电细胞-基质阻抗传感(ECIS)进行量化。细胞骨架力传递到细胞外基质的研究将使用微图硅柱来报告局部(接近离散入侵事件)和感染细胞和单层的全局变化。这些研究将为确定减轻脑微血管中大肠杆菌K1疾病的治疗靶点提供更详细的概念框架。对E机制的洞察。这里获得的大肠杆菌入侵可能为研究其他器官系统的大肠杆菌疾病提供有用的范例。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LEWIS H ROMER其他文献
LEWIS H ROMER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LEWIS H ROMER', 18)}}的其他基金
INFLAMMATORY CYTOKINE EFFECTS ON CELL ADHESION IN PULMONARY VASCULAR EPITHELIUM
炎症细胞因子对肺血管上皮细胞粘附的影响
- 批准号:
6410547 - 财政年份:2000
- 资助金额:
$ 24.36万 - 项目类别:
INFLAMMATORY CYTOKINE EFFECTS ON CELL ADHESION IN PULMONARY VASCULAR EPITHELIUM
炎症细胞因子对肺血管上皮细胞粘附的影响
- 批准号:
6202501 - 财政年份:1999
- 资助金额:
$ 24.36万 - 项目类别:
相似海外基金
A novel motility system driven by two classes of bacterial actins MreB
由两类细菌肌动蛋白 MreB 驱动的新型运动系统
- 批准号:
22KJ2613 - 财政年份:2023
- 资助金额:
$ 24.36万 - 项目类别:
Grant-in-Aid for JSPS Fellows
EGF Receptor Endocytosis: Mechanisms and Role in Signaling
EGF 受体内吞作用:机制及其在信号传导中的作用
- 批准号:
10552100 - 财政年份:2023
- 资助金额:
$ 24.36万 - 项目类别:
Mitochondrial positioning regulates redox-signaling during cell migration
线粒体定位调节细胞迁移过程中的氧化还原信号
- 批准号:
10520211 - 财政年份:2023
- 资助金额:
$ 24.36万 - 项目类别:
Thick and Thin Filament Dysfunction in Obese Heart Failure with Preserved Ejection Fraction
射血分数保留的肥胖性心力衰竭的粗细丝功能障碍
- 批准号:
10678204 - 财政年份:2023
- 资助金额:
$ 24.36万 - 项目类别:
Mechanical signaling through the nuclear membrane in lung alveolar health
通过核膜的机械信号传导影响肺泡健康
- 批准号:
10677169 - 财政年份:2023
- 资助金额:
$ 24.36万 - 项目类别:
Cytoskeleton-mediated regulation of insulin secretion hot spots in pancreatic beta cells
细胞骨架介导的胰腺β细胞胰岛素分泌热点的调节
- 批准号:
10679903 - 财政年份:2023
- 资助金额:
$ 24.36万 - 项目类别:
Decoding dynamic interplay between signaling and membranes in chemotaxis bymolecular actuators
通过分子致动器解码趋化中信号传导和膜之间的动态相互作用
- 批准号:
10846921 - 财政年份:2023
- 资助金额:
$ 24.36万 - 项目类别:
Modulators of cardiomyocyte structure to promote functional recovery during cardiac regeneration and repair
心肌细胞结构调节剂促进心脏再生和修复过程中的功能恢复
- 批准号:
10751640 - 财政年份:2023
- 资助金额:
$ 24.36万 - 项目类别:
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
- 批准号:
10603436 - 财政年份:2023
- 资助金额:
$ 24.36万 - 项目类别:
Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodies
用他汀类药物靶向转录共激活剂 YAP 和 TAZ,以防止 HLA 供体特异性抗体导致实体器官移植排斥
- 批准号:
10734277 - 财政年份:2023
- 资助金额:
$ 24.36万 - 项目类别:














{{item.name}}会员




